{"id":652603,"date":"2023-05-23T20:14:01","date_gmt":"2023-05-23T20:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=652603"},"modified":"2023-05-23T20:14:01","modified_gmt":"2023-05-23T20:14:01","slug":"onychosis-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-veloce-biopharmaceuticals-blueberry-therapeutics-pfizer-galderma-moberg-biophar","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/onychosis-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-veloce-biopharmaceuticals-blueberry-therapeutics-pfizer-galderma-moberg-biophar_652603.html","title":{"rendered":"Onychosis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies &#8211; Veloce Biopharmaceuticals, Blueberry Therapeutics, Pfizer, Galderma, Moberg Biophar"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Onychosis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Veloce Biopharmaceuticals, Blueberry Therapeutics, Pfizer, Galderma, Moberg Biophar\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Onychosis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Veloce Biopharmaceuticals, Blueberry Therapeutics, Pfizer, Galderma, Moberg Biophar\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Onycholysis Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Onycholysis, historical and forecasted epidemiology as well as the Onycholysis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s&nbsp;<strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/onycholysis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Onycholysis Market Insights, Epidemiology, and Market Forecast-2032<\/a>&#8220;<\/strong>&nbsp;report delivers an in-depth understanding of the Onycholysis, epidemiology insights,&nbsp;Onycholysis market trends, therapies, and key companies working in the&nbsp;Onycholysis Market in the 7MM.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Onychosis&nbsp; Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Onycholysis is a common medical condition characterized by the painless detachment of the nail from the nail bed, usually starting at the tip and sides. On the hands, it occurs mainly on the ring finger but can appear on any fingernail. It may also happen to toenails. Onycholysis can occur in many conditions, including psoriasis. In thyrotoxicosis, it is thought to be due to sympathetic overactivity. It may also be seen in infections or trauma.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/5acc7c07320ba435ebf6ed9e065c5e4f.png\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Onychosis Epidemiology Insights<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">A retrospective study was carried out from 01\/01\/2015 to 31\/12\/2017 based on files of patients who visited the outpatient clinic of the hospital &ldquo;Andreas Syggros&rdquo; (Athens, Greece) with clinical signs of possible onychomycosis. The study protocol was approved by the ethics committee of the hospital.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">There were 3,548 visits recorded during this period. After excluding patients with multiple stops, there remained 3,226 adult patients (904 men and 2,322 women) who were evaluated for possible onychomycosis.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Click here to learn more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/onycholysis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Onychosis Market Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The Report Covers the Onychosis&nbsp; Epidemiology Segmented by:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total Onychosis incident cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total Onychosis prevalent cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total Onychosis treatment cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total Onychosis diagnostic cases&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Onychosis Market Outlook&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The Onycholysis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Onycholysis market trends by analyzing the impact of current Onycholysis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">This segment gives a thorough detail of the Onycholysis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Onycholysis market data are presented with relevant tables and graphs to give a clear picture of the market at first sight.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">According to DelveInsight, the Onycholysis market in 7MM is expected to change in the study period 2019-2032.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Key Companies Working in the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/onycholysis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Onychosis Market<\/a><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Veloce Biopharmaceuticals&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Blueberry Therapeutics&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Pfizer&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Galderma&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Moberg Biopharmaceuticals&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Onychosis Therapies Covered and Analyzed in the Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">VBP-926<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Amorolfine<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">BB2603-1<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Ciclopirox<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Albaconozole<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/onycholysis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Key Companies and Emerging Therapies in the Onychosis Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>&nbsp;Table of Contents&nbsp;<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Key Insights&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Onychosis&nbsp; Introduction&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Executive Summary of Onychosis&nbsp;&nbsp;&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Disease Background and Overview<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Epidemiology and patient population<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Onychosis Emerging Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Onychosis Market Outlook<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Market Access and Reimbursement of Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Market Drivers&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Market Barriers&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Appendix<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Report Methodology<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">DelveInsight Capabilities<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Disclaimer<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn about the detailed offerings of the report @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/onycholysis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\"> Onychosis Market Outlook<\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75707.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Adya Kaul<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=onychosis-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-veloce-biopharmaceuticals-blueberry-therapeutics-pfizer-galderma-moberg-biophar\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/due-diligence-services<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=onychosis-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-veloce-biopharmaceuticals-blueberry-therapeutics-pfizer-galderma-moberg-biophar\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Onycholysis Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Onycholysis, historical and forecasted epidemiology as well as the Onycholysis market trends in the United States, EU4 (Germany, Spain, Italy, France, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/onychosis-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-veloce-biopharmaceuticals-blueberry-therapeutics-pfizer-galderma-moberg-biophar_652603.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,417,406,403,404],"tags":[],"class_list":["post-652603","post","type-post","status-publish","format-standard","hentry","category-Business","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/652603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=652603"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/652603\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=652603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=652603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=652603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}